A61P 3 - Drugs for disorders of the metabolism

Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
11/2004
11/25/2004	US20040235845 Use of phosphodiesterase iv inhibitors
11/25/2004	US20040235838 Use of 2-alkoxyphenol-substituted imidazotriazinones
11/25/2004	US20040235837 Method for treating fibrotic diseases or other indications IE
11/25/2004	US20040235833 5-[(2R)-2-({(2R)-2-hydroxy-2-[4-hydroxy-3-(hydroxymethyl) phenyl]ethyl}amino) propyl]-N-(2-methoxybenzyl)-1H-indole-2-carboxamide for example; asthma, bronchitis, and emphysema; beta-2 adrenergic receptor agonists
11/25/2004	US20040235830 Substituted cyclohexane derivatives and the use thereof in medicaments for treating cardiovascular diseases
11/25/2004	US20040235825 Administering compounds such as N-[4-[2-[2-(1-naphthyl)propanoylamino]phenyl]butanoyl]-(3,5-dimethylisoxazol-4-yl)sulfonamide for prophylaxis and therapy of pain, allodynia, hyperalgesia, pruritus, urticaria, atopic dermatitis, contact dermatitis, allergic conjunctivitis, asthma, rhinitis, sneeze
11/25/2004	US20040235816 Administering compounds such as 1-benzhydryl-3-[(methylsulfonyl)(phenyl)methylene]azetidine for therapy of schizophrenia, Parkinson's disease, and Alzeimer's disease
11/25/2004	US20040235808 Administering compounds such as 17 beta -[4-(dimethylamino)-benzoyloxy]-androst-4-en-3-one for modulating a function mediated by the androgen receptor in a tissue selective manner
11/25/2004	US20040235795 Administration of an agent produced from phosphatidylserine (PS), lyso-phosphatidylserine or/and a physiologically acceptable salt thereof in combination with additive selected from a group comprising antioxidants, essential fatty acids, mineral substances, amino acids, mood-lifters, phospholipids
11/25/2004	US20040235764 Methods of inhibiting expression of a target gene in mammalian cells
11/25/2004	US20040235752 3-fluoro-pyrrolidines as antidiabetic agents
11/25/2004	US20040235720 May also be used in combination with an interferon for treatment and/or prevention of diseases such as traumatic nerve injury, stroke, demyelinating diseases of the CNS or PNS, neuropathies and neurodegenerative diseases
11/25/2004	US20040235710 Comprising a GLP-1 compound and an acylated basal insulin or a pI shifted basal insulin; can be used to treat diseases such as non-insulin dependent diabetes mellitus and insulin dependent diabetes mellitus, hyperglycemia, obesity
11/25/2004	US20040235709 Gssp3 polynucleotides and polypeptides and uses thereof
11/25/2004	US20040235123 Transgenic escherichia for use as bioreactor in fermentation of alpha-lipoic acid for use in animal feeds, medicines and cosmetics
11/25/2004	US20040235006 Chemical compounds
11/25/2004	US20040234674 Artichoke leaf extracts
11/25/2004	US20040234666 Method of extracting casein fractions from milk and caseinates and production of novel products
11/25/2004	US20040234634 Pharmaceutical compositions having appetite suppressant activity
11/25/2004	US20040234631 Composition comprising soy and use thereof in the provention and/or treatment of various diseases
11/25/2004	US20040234626 Food supplement for increasing lean mass and strength
11/25/2004	US20040234617 Water extraction; centrifuging; separation; cooling; freeze drying; hypotensive agents
11/25/2004	US20040234601 Absorption in upper part oof digestive system; oral administering
11/25/2004	US20040234575 Medical products comprising a haemocompatible coating, production and use thereof
11/25/2004	US20040234555 Using 5-aminolevulinic acid
11/25/2004	US20040234522 therapy, diagnosis of immunology diseases; response to antigenic stimulants; cell differentiation of lymphocytes
11/25/2004	US20040234518 Composition, methods and reagents for the synthesis of a soluble form of human PHEX
11/25/2004	DE10308351A1 1,3-substituierte Cycloalkylderivate mit sauren, meist heterocyclischen Gruppen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel 1,3-substituted cycloalkyl derivatives having acidic, mostly heterocyclic groups, processes for their preparation and their use as medicaments
11/25/2004	CA2526025A1 Preventive and/or remedy for diseases accompanied by tissue destruction
11/25/2004	CA2525442A1 Cyanofluoropyrrolidine derivatives
11/25/2004	CA2525316A1 Pioglitazone salts, such as pioglitazone sulfate, and pharmaceutical compositions and processes using the same
11/25/2004	CA2524958A1 Isoquinoline derivatives and their use as gfat inhibitors
11/25/2004	CA2524780A1 Compounds for treatment of inflammation, diabetes and related disorders
11/25/2004	CA2524228A1 Method of preparing a formulation containing a microdosed active principle
11/24/2004	EP1479768A1 Novel screening method
11/24/2004	EP1479671A1 Pyrimidinone compounds
11/24/2004	EP1479666A1 Ester compound and medicinal use thereof
11/24/2004	EP1479394A1 The use of epidermal growth factor (EGF) for increasing weight gain in an animal
11/24/2004	EP1479300A1 Amino acid powder and process for producing the same
11/24/2004	EP1478762A2 Nucleic acid-associated proteins
11/24/2004	EP1478745A2 Kinases and phosphatases
11/24/2004	EP1478732A1 A selenium yeast product, a method of preparing a selenium yeast product and the use of the product for preparing food, a dietary supplement or a drug
11/24/2004	EP1478659A2 Biologically active peptides
11/24/2004	EP1478648A2 Phosphorus-containing compounds uses thereof
11/24/2004	EP1478645A2 Quinolinone derivatives for treating cell proliferation related disorders
11/24/2004	EP1478640A1 Process for the manufacture of hmg-coa reductase inhibitory mevalonic acid derivatives
11/24/2004	EP1478630A2 Process and intermediates for preparing phenylthiomethyl-thiazoles or -oxazoles
11/24/2004	EP1478626A2 Guanidino compounds
11/24/2004	EP1478625A1 Processes and intermediates useful in preparing beta-3-adrenergic receptor agonists
11/24/2004	EP1478624A1 Chemical compounds
11/24/2004	EP1478437A1 Acc inhibitors
11/24/2004	EP1478401A2 Compositions comprising dietary fat complexer and methods for their use
11/24/2004	EP1478393A2 Anti-pathogen treatements
11/24/2004	EP1478369A1 Use of biogenic estriol diester prodrugs for the treatment of autoimmune diseases
11/24/2004	EP1478368A1 Use of benzothiazepines having activity as inhibitors of ileal bile acid transport for reducing cholesterololemia
11/24/2004	EP1478361A2 Arylsulfone derivatives
11/24/2004	EP1478358A1 Aryl ureas with angiogenesis inhibiting activity
11/24/2004	EP1478353A1 Sustained release pharmaceutical composition
11/24/2004	EP1478276A2 Novel targeted compositions for diagnostic and therapeutic use
11/24/2004	EP1478236A2 Targeted retrograde gene delivery to motor neurons
11/24/2004	EP1478233A2 Method for administering glp-1 molecules
11/24/2004	EP1434790A4 Calcium-influx inhibitory factor and method of isolation thereof
11/24/2004	EP1420799A4 Use of atazanavir in hiv therapy
11/24/2004	EP1318976B1 Substituted aminopropoxyaryl derivatives useful as agonists for lxr
11/24/2004	EP1313496B1 Use of a composition comprising an extract of pollen for the treatment of edema
11/24/2004	EP1313495B1 Use of a composition comprising an extract of pollen for the treatment of hormonally-related disorders
11/24/2004	EP1313493B1 Use of a composition comprising an extract of pollen for the treatment of irritability
11/24/2004	EP1313492B1 Use of a composition comprising an extract of pollen for the treatment of dysphoria
11/24/2004	EP1305306B1 2-adamantylethylamines and their use in the treatment of conditions generally associated with abnormalities in glutamatergic transmission
11/24/2004	EP1285000B1 Adnf mixtures for enhancing learning and memory
11/24/2004	EP1272201B1 Use of compatible solutes as substances having free radical scavenging properties
11/24/2004	EP1263747B1 1,5-benzothiazepines and their use as hypolipidaemics
11/24/2004	EP1259498B1 8,8a-dihydro-indeno 1,2-d]thiazole derivatives, substituted in position 8a, a method for their production and their use as medicaments, e.g. anorectic agents
11/24/2004	EP1175214B1 Cyclooxygenase-2 inhibitor compositions having rapid onset of therapeutic effect
11/24/2004	EP1146883A4 Modulation of immune response by ribavirin
11/24/2004	EP1144673A4 Methods of screening protease inhibitors, of inducing mice susceptible to hiv protease inhibitor-induced dyslipidemia, and genes associated therewith
11/24/2004	EP1109572A4 Neuroprotection
11/24/2004	EP1098655B1 Nutritional and therapeutic uses of 3-hydroxyalkanoate oligomers
11/24/2004	EP1094711B1 Methods for eradication of nanobacteria
11/24/2004	CN1549862A Transgenic plants expressing cobalamin binding proteins
11/24/2004	CN1549826A Compositions and methods of treating diabetes
11/24/2004	CN1549816A N-aroyl cyclic amine derivatives as orexin receptor antagonists
11/24/2004	CN1549814A Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor type-1 (PAI-1)
11/24/2004	CN1549812A Pyrazole compounds useful as protein kinase inhibitors.
11/24/2004	CN1549809A Dithiazole compounds, matrix metalloprotease inhibitors and external preparations for the skin
11/24/2004	CN1549803A 维生素d的类似物 Analogs of vitamin d
11/24/2004	CN1549730A Compositions and methods of using capsid protein from flaviviruses and pestiviruses
11/24/2004	CN1549715A Piperidin-2,6-dione salts and its use in the treatment of stress-related affective disorders
11/24/2004	CN1549713A Diaryl cycloalkyl derivatives, the use thereof as PPAR activators and pharmaceutical compositions containing thereof
11/24/2004	CN1549710A Compositions comprising pectin and ascorbic acid
11/24/2004	CN1548540A Polypeptide enzyme surface exhibiting technology and C-end polypeptide enzyme surface exhibition of cholesteryl ester transfer protein
11/24/2004	CN1548443A Phenol containing diphosphonic acid derivative and its prepn and application
11/24/2004	CN1548436A Novel 2-alkyl substituted imidazole compounds
11/24/2004	CN1548432A Stabilizing method and medicine composition of catechin monomer
11/24/2004	CN1548142A Medicine for improving sugar tolerance and treating diabetes and its prepn process
11/24/2004	CN1548108A Slimming bolus and its prepn
11/24/2004	CN1548099A Xiaokelingwan-diabetes treating bolus and its prepn
11/24/2004	CN1548070A Nutrient with vitamines
11/24/2004	CN1548059A Soft hypolipidemic Jiaosuan capsule and its production process
11/24/2004	CN1548051A Tillering onion extract and its application

1 ... 765 766 767 768 769 770 771 772 773 774 775 776 777 778 779 780 781 782 783 784 785 ... 1298